Expression of Wnt5a, Fzd3, and Fzd5 in non-melanoma skin cancer.<sup>1</sup>
Celine Pourreyron
Louise Reilly
Charlotte Proby
Andrey Panteleyev
Colin Fleming
Kathleen McLean
Andrew P. South
John Foerster
10.1371/journal.pone.0031827.t001
https://plos.figshare.com/articles/dataset/_Expression_of_Wnt5a_Fzd3_and_Fzd5_in_non_melanoma_skin_cancer_1_/348773
1<p>Immunohistochemistry of formaldehyde-fixed paraffin-embedded SCC (n = 12) and BCC (n = 9) samples was carried out as described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0031827#s2" target="_blank">Methods</a>.</p>2<p>Expression level was scored as “moderate” when staining intensity was comparable, as “strong” when staining was stronger, and as “low” when staining was weaker than that of epidermis present in the same section, respectively.</p>
2012-02-22 02:26:13
fzd5
non-melanoma